Alembic Pharmaceuticals gets EIR from USFDA for Karakhadi facility

08 Jul 2016 Evaluate

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food & Drug Administration (USFDA). The regulator had carried out the inspection at the Company's Karakhadi API Plant III in April, 2015.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

1038.95 -16.05 (-1.52%)
23-Dec-2024 09:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1803.20
Dr. Reddys Lab 1359.35
Cipla 1464.90
Lupin 2145.70
Zydus Lifesciences 967.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.